Abstract
Pancreatic cancer is one of the most lethal cancers and leading cause of cancer related death worldwide. Due to its nonspecific early symptoms, pancreatic cancer is difficult to diagnose before extensive local invasion and distant metastasis. The 5-year survival rate of patients diagnosed with pancreatic cancer is less than 5%. Their median survival time is less than 12 months. The molecular mechanisms of pancreatic tumor genesis are poorly understood. Mesothelin is a glycosylphosphatidylinositol (GPI) anchored cell surface protein, which has been found overexpressed in human pancreatic cancer. The function of mesothelin in tumor progression remains unclear. This review aims to outline the roles of mesothelin in pancreatic cancer cell proliferation, apoptosis and invasion, as well as its potential role in mesothelintargeted cancer therapy. Therefore, mesothelin is malignant factor for pancreatic cancer and could be exploited as an antigenic target of therapeutic cancer vaccine.
Keywords: Function, mesothelin, pancreatic cancer.
Current Signal Transduction Therapy
Title:Clinical Significance of Mesothelin in Pancreatic Cancer
Volume: 11 Issue: 1
Author(s): Lei Zhang, Xiaoling Ni and Dayong Jin
Affiliation:
Keywords: Function, mesothelin, pancreatic cancer.
Abstract: Pancreatic cancer is one of the most lethal cancers and leading cause of cancer related death worldwide. Due to its nonspecific early symptoms, pancreatic cancer is difficult to diagnose before extensive local invasion and distant metastasis. The 5-year survival rate of patients diagnosed with pancreatic cancer is less than 5%. Their median survival time is less than 12 months. The molecular mechanisms of pancreatic tumor genesis are poorly understood. Mesothelin is a glycosylphosphatidylinositol (GPI) anchored cell surface protein, which has been found overexpressed in human pancreatic cancer. The function of mesothelin in tumor progression remains unclear. This review aims to outline the roles of mesothelin in pancreatic cancer cell proliferation, apoptosis and invasion, as well as its potential role in mesothelintargeted cancer therapy. Therefore, mesothelin is malignant factor for pancreatic cancer and could be exploited as an antigenic target of therapeutic cancer vaccine.
Export Options
About this article
Cite this article as:
Zhang Lei, Ni Xiaoling and Jin Dayong, Clinical Significance of Mesothelin in Pancreatic Cancer, Current Signal Transduction Therapy 2016; 11 (1) . https://dx.doi.org/10.2174/1574362411666160210232918
DOI https://dx.doi.org/10.2174/1574362411666160210232918 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting the RAS Signaling Pathway in Malignant Hematologic Diseases
Current Drug Targets Cytotoxic Effect of the Red Beetroot (Beta vulgaris L.) Extract Compared to Doxorubicin (Adriamycin) in the Human Prostate (PC-3) and Breast (MCF-7) Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry A Filter Based Feature Selection Algorithm Using Null Space of Covariance Matrix for DNA Microarray Gene Expression Data
Current Bioinformatics Editorial (Thematic Issue: Novel Pharmaceutical Approaches by Natural Compound-Derived Epigenetic Regulators: Epigenetic Readers, Writers and Erasers as Therapeutic Targets)
Current Topics in Medicinal Chemistry The Potential for Targeting Oncogenic WNT/β -Catenin Signaling in Therapy
Current Drug Targets Organoselenium Compounds in Cancer Chemoprevention
Mini-Reviews in Medicinal Chemistry Role of the Non-Neuronal Human Cholinergic System in Lung Cancer and Mesothelioma: Possibility of New Therapeutic Strategies
Current Medicinal Chemistry - Anti-Cancer Agents The Management of Thymoma - A Review of the Status Quo with Practical Treatment Recommendations
Current Respiratory Medicine Reviews Genetics and Epigenetics of Lung Cancer: Mechanisms and Future Perspectives
Current Cancer Therapy Reviews Ultrasound Characteristics in Complicated Ovarian Cysts
Current Women`s Health Reviews Validated RP-HPLC Method for the Simultaneous Analysis of Gemcitabine and LY-364947 in Liposomal Formulations
Current Drug Targets miR-149 as a Potential Molecular Target for Cancer
Current Medicinal Chemistry Role of the Receptor Tyrosine Kinase Axl and its Targeting in Cancer Cells
Current Medicinal Chemistry Advances in Nanomedicine Towards Clinical Application in Oncology and Immunology
Current Pharmaceutical Biotechnology HLA-G Expression in Cancers: Potential Role in Diagnosis, Prognosis and Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of PET/CT and SPECT/CT in Oncology Drug Development
Current Molecular Imaging (Discontinued) Is Src a Viable Target for Treating Solid Tumours?
Current Cancer Drug Targets Doxorubicin-Loaded Nanoparticles: New Advances in Breast Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Medulloblastoma: Role of Developmental Pathways, DNA Repair Signaling, and Other Players
Current Molecular Medicine Bisphosphonates: Molecular Mechanisms of Action and Effects on Bone Cells, Monocytes and Macrophages
Current Pharmaceutical Design